CSFB Cuts Andrx to Hold

Analyst David Maris says fourth-quarter earnings were well below his estimates and the Wall Street consensus

Credit Suisse First Boston downgraded its rating on shares of Andrx Group (ADRX ) to hold from buy after the company reported $0.06 fourth quarter EPS (pro forma).

To continue reading this article you must be a Bloomberg Professional Service Subscriber.